Pan Drugs Ltd - Stock Valuation and Financial Performance

Name: Pan Drugs
Brand: Pan Drugs

BSE: 531440 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Pan Drugs

Based on:

Data

M-Cap below 100cr DeciZen not available

Pan Drugs stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0.6 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Pan Drugs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	TTM
ROCE % ⓘ	0%	0%	0%	0%	0%	0%	0%	-9.8%	-2.9%	2.6%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	19.8	19.4	30.8	24
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-2%	58.9%	-
Adj EPS ⓘ	0	0	0	0	0	0	0	-3.7	-1.1	0.8	-2.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	0	0	0	0	0	0	0	-26	-26.9	-26	10
Adj Net Profit ⓘ	0	0	0	0	0	0	0	-1.2	-0.4	0.3	-1
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	0	0	0.4	1	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	47	18.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	58.9%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'12	Mar'13	Mar'14	TTM
Return on Equity % ⓘ	14	4.3	-3.1	28.4
Op. Profit Mgn % ⓘ	-4.3	-7.3	-0.1	2.3
Net Profit Mgn % ⓘ	-5.8	-1.9	0.8	-3
Debt to Equity ⓘ	-2.4	-2.3	-2.4	-
Working Cap Days ⓘ	0	190	128	60
Cash Conv. Cycle ⓘ	0	10	-17	-74

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Pan Drugs Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-2.3	-
TTM Sales (₹ Cr.)	24.2	-
BVPS (₹.) ⓘ	10	-
Reserves (₹ Cr.) ⓘ	-	-
P/BV ⓘ	0.20	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	0.60 / 13.00
Market Cap (₹ Cr.)	0.6
Equity (₹ Cr.)	3.1
Face Value (₹)	10
Industry PE ⓘ	47.2

Management X-Ray of Pan Drugs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Pan Drugs

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Pan Drugs

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14
Sales	19.76	19.37	30.77
Operating Expenses ⓘ	20.62	20.79	30.81
Manufacturing Costs	2.21	2.71	1.85
Material Costs	15.75	14.83	25.06
Employee Cost	1.55	1.50	1.88
Other Costs ⓘ	1.12	1.75	2.01
Operating Profit ⓘ	-0.86	-1.42	-0.04
Operating Profit Margin (%)	-4.3%	-7.3%	-0.1%
Other Income ⓘ	0.44	1.71	0.97
Interest ⓘ	0.07	0.04	0.04
Depreciation ⓘ	0.46	0.52	0.61
Exceptional Items ⓘ	0	0	0
Profit Before Tax ⓘ	-0.94	-0.27	0.28
Tax ⓘ	0	0	0
Profit After Tax	-0.94	-0.27	0.28
PAT Margin (%)	-4.8%	-1.4%	0.9%
Adjusted EPS (₹)	-3.0	-0.9	0.9
Dividend Payout Ratio (%)	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14
Equity and Liabilities
Shareholders Fund	-8.18	-8.45	-8.18
Share Capital ⓘ	3.14	3.14	3.14
Reserves ⓘ	-11.32	-11.60	-11.32
Minority Interest	0	0	0
Debt	19.42	19.65	19.18
Long Term Debt	0.07	0.13	0.10
Short Term Debt	19.35	19.52	19.08
Trade Payables	4.48	6.53	8.58
Others Liabilities ⓘ	4.25	1.64	2.17
Total Liabilities ⓘ	19.96	19.37	21.76
Fixed Assets
Gross Block	10.38	12.23	13.32
Accumulated Depreciation	5.28	5.80	6.36
Net Fixed Assetsⓘ	5.10	6.43	6.95
CWIP ⓘ	1.14	0	0
Investmentsⓘ	0	0	0
Inventories	2.23	2.17	2.44
Trade Receivables	4.79	3.91	6.08
Cash Equivalents	1.99	1.97	1.47
Others Assetsⓘ	4.71	4.89	4.81
Total Assets ⓘ	19.96	19.37	21.76

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14
Cash Flow From Operating Activity ⓘ	0.42	1.02
PBT ⓘ	-0.27	0.28
Adjustment ⓘ	0.49	0.53
Changes in Working Capital ⓘ	0.2	0.21
Tax Paid ⓘ	0	0
Cash Flow From Investing Activity ⓘ	-0.63	-1
Capex	-0.71	-1.12
Net Investments	0	0
Others ⓘ	0.08	0.12
Cash Flow From Financing Activityⓘ	0.19	-0.51
Net Proceeds from Shares ⓘ	0	0
Net Proceeds from Borrowing ⓘ	0	0
Interest Paid ⓘ	-0.04	-0.04
Dividend Paid ⓘ	0	0
Others ⓘ	0.23	-0.47
Net Cash Flow ⓘ	-0.03	-0.49

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14
Ratios
ROE (%)	N/A	N/A	N/A
ROCE (%)	N/A	N/A	N/A
Asset Turnover Ratio	1.12	1.11	1.68
PAT to CFO Conversion(x)	N/A	N/A	3.64
Working Capital Days
Receivable Days	78	73	53
Inventory Days	36	37	24
Payable Days	104	136	110

Pan Drugs Ltd Stock News

Pan Drugs Ltd FAQs

What is the share price of Pan Drugs?

Company share prices are keep on changing according to the market conditions. The closing price of Pan Drugs on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Pan Drugs?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Pan Drugs stood at ₹0.64.